Simplified Pulmonary Embolism Severity Index in Predicting Mortality in Emergency Department
Abstract
AMAÇ: Pulmoner emboli (PE) mortalite, morbidite ve hastane yatışının en önemli nedenlerinden biridir. Bu çalışmada pulmoner embolide Basitleştirilmiş Pulmoner Emboli Ölçeği İndeksi (sPESI) ile hastaların 3 aylık mortalite ilişkisini araştırmayı amaçladık.
GEREÇ VE YÖNTEM: Çalışmaya toplam 118 hasta dahil edildi. PE tanısından 3 ay sonra ölen hastalar Grup 1 olarak tanımlandı. Diğer hastalar Grup 2 olarak tanımlandı. SPESI skoru hesaplandı ve kaydedildi. Bu skorlama sistemlerinin 3 aylık mortalite üzerine etkisi araştırıldı.
BULGULAR: Grup 1'de 31 hasta (% 26.3) ve Grup 2'de 87 hasta (% 73.7) vardı. Hastaların sPESI skorları incelendiğinde Grup 1 ve 2 arasında 3 aylık mortalite açısından fark vardı. 3 aylık mortaliteyi öngörmede sPESI% 43.3 duyarlılık ve% 79.4 özgüllük göstermiştir.
SONUÇ: Acil serviste PE tanısı alan hastalarını risk profillerine göre ayırmak tedavi ihtiyaçlarını belirlemek açısından önemlidir.
ABSTRACT
BACKGROUND: Pulmonary embolism (PE) is one of the major causes of mortality, morbidity and hospital admission. We aimed to investigate the association of the Simplified Pulmonary Embolism Severity Index (sPESI) and mortality within 3 months.
MATERIALS AND METHODS: A total of 118 patients were included in the study. Patients who died within 3 months after PE diagnosis were defined as Group 1. Other patients were defined as Group 2. The sPESI score was calculated and recorded. The effect of these scoring systems on 3-month mortality rate was investigated.
RESULTS: There were 31 patients (26.3%) in Group 1 and 87 patients (73.7%) in Group 2. When the sPESI scores of the patients were examined, there was difference between Group 1 and 2 in terms of 3-month mortality. The sPESI had a sensitivity of 43.3% and a specificity of 79.4% for predicting 3-month mortality.
CONCLUSION: It is important to categorize patients diagnosed with PE in the emergency department according to their risk profiles in terms of their treatment needs.
Keywords
References
- REFERENCES1. Torbicki A, Perrier A, Konstantinides SV, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J
- 2. Tapson VF. Acute pulmonary embolism. N Engl J Med 2008; 358: 1037–1052.
- 3. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008; 133: 454S–545S. 4. Jime´nez D, Yusen RD. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Current Opin Pulm Med 2008; 14: 414–421.
- 5. Jime´nez D, Yusen RD, Otero R, et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest 2007; 132: 24–30.
- 6. Aujesky D, Roy PM, Le Manach CP, et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 2006; 27: 476–481.
- 7. Donze J, Le Gal G, Fine MJ, et al. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost 2008; 100: 943–948.
- 8. Aujesky D, Perrier A, Roy PM, et al. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med 2007; 261: 597–604.
- 9. Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, Roy PM, Fine MJ. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172:1041–1046.
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Research Article
Authors
Pınar Yeşim Akyol
*
Türkiye
Publication Date
June 28, 2019
Submission Date
January 10, 2019
Acceptance Date
June 8, 2019
Published in Issue
Year 2019 Volume: 11 Number: 2


